Emmanuel Stylianos Antonarakis

Professor of Medicine, Associate Director for Translation

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Emmanuel Stylianos Antonarakis is a Professor of Medicine and the Associate Director for Translation at the Masonic Cancer Center, University of Minnesota, USA. His research focuses on advancements in prostate cancer treatment, specifically through the study of homologous recombination repair alterations and the implications of novel genetic findings in malignancy. Recent publications emphasize the importance of genetic testing and personalized approaches in managing prostate cancer.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Andrew Armstrong

Professor

Duke Cancer Institute

UNITED STATES

Emmanuel Stylianos Antonarakis

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

CH Mutations in 16,812 Advanced Cancer Patients–Letter

The Influence of the Germline <i>HSD3B1</i> Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer

Novel MAML2 Fusions in Human Malignancy

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer

Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial

CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancer

Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers

Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer

A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer

Clinical outcomes in patients with metastatic castrate‐resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retrospective case–control study

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary?

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

Impact of piflufolastat F‐18 PSMA PET imaging on clinical decision‐making in prostate cancer across disease states: A retrospective review

PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer

MLH1 Loss in Primary Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond

Radiotheranostics in advanced prostate cancer: Current and future directions

Collaborators (18)

Andrew Armstrong

Pedro Barata

Katherine Nathanson

Justin Hwang

Chadi Hage Chehade

AKASH ROY

Niven Mehra

Catherine Marshall

Lukasz P Gondek

Zeynep Irem Ozay

Alan Haruo Bryce

Susan Halabi

Carly Miller

Eric Konnick

Sumit Subudhi

Colin Pritchard

Takefumi Komiya

Jae Lyun Lee

Make your next move.